Showing results (411-420 of 2,511) with videos related to
Sort By:
Pageof 252
Inflammopharmacology|July 22, 2015
Protective effect of Blumea lacera DC aerial parts in indomethacin-induced enterocolitis in ratsSantosh Basnet, Ashish Adhikari, Vijaya Kumar Sachidananda, et al.Inflammopharmacology|March 8, 2023
Neuroprotective effect of tangeretin against chromium-induced acute brain injury in rats: targeting Nrf2 signaling pathway, inflammatory mediators, and apoptosisAhmed A Sedik, Rania ElgoharyInflammopharmacology|January 27, 2023
High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single centerMurat Bektaş, Servet Yüce, Mustafa Ay, et al.Inflammopharmacology|February 17, 2026
Therapeutic potential of Celtis eriocarpa Decne.: in vivo and in vitro antiarthritic effects supported by GC‒MS and qRT‒PCR analysisAsra Shanzeh Shabbir, Malik Saadullah, Shazia Anwer BukhariInflammopharmacology|February 16, 2026
Curcumin-piperine liposomal hydrogel formulation for topical management of atopic dermatitis and associated skin inflammation: optimization, in vitro and in vivo studiesDyandevi Mathure, Vaishnavi Bhise, Malati Salunke, et al.Inflammopharmacology|February 13, 2010
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's diseaseLynn W Maines, Leo R Fitzpatrick, Cecelia L Green, et al.Inflammopharmacology|July 1, 2020
Correction to: 4-Phenylbutyric acid protects against vasculitic peripheral neuropathy induced by ischaemia-reperfusion through attenuating endoplasmic reticulum stressCay-Huyen Chen, Ping-Chen Shih, Han-Yu Lin, et al.Inflammopharmacology|February 6, 2026
Postmarketing adverse events of biologics and Janus kinase inhibitors in patients with atopic dermatitisYaping Huang, Qing Zhou, Chengjie Ke, et al.Inflammopharmacology|January 30, 2026
Wild chrysanthemum essential oil alleviates dry eye disease by inhibiting NF-κB-mediated inflammationShunxin Tang, Mengrui Cai, Fujia Li, et al.Inflammopharmacology|January 19, 2026
Diosgenin-mediated NF-κB and MAPK pathway modulation for osteoarthritis treatment: molecular mechanisms, bioavailability enhancement, and therapeutic applicationsRudresh Adarkar, Vijishna Lekshmi Viswambharan, Akanksha Dessai, et al.Pageof 252